Anxiety over a Chinese startup’s threat to American artificial intelligence dominance faded further Wednesday as investors turned their focus to the Federal Reserve’s rate decision due later in the da ...
On the winning side of Wall Street were Novo Nordisk’s U.S.-listed shares, which jumped 8.6%. The Danish company reported results from a clinical trial of a treatment for people who are overweight or ...